Literature DB >> 8660582

Simultaneous determination of adenosine, inosine, hypoxanthine, xanthine, and uric acid in microdialysis samples using microbore column high-performance liquid chromatography with a diode array detector.

D A Mei1, G J Gross, K Nithipatikom.   

Abstract

In the myocardial interstitial space, adenosine and its metabolites are important markers of ischemia, regulators of blood flow, and may produce cardioprotection against ischemia. A fast and sensitive method to assess the concentrations of adenosine and its metabolites is necessary to determine their involvement in mediating these effects. A method for the simultaneous determination of adenosine, inosine, hypoxanthine, xanthine, and uric acid in the interstitial fluid of the canine myocardium was developed using microdialysis, microbore column high-performance liquid chromatography, and a photo diode array detector (DAD). The microdialysis samples were injected directly onto a microbore C18 reverse-phase column without any prior sample preparation. Use of a DAD in this method provided many advantages. First, a DAD allowed the simultaneous detection of UV absorbance at multiple wavelengths, allowing the detection of each compound at their maximal UV absorbance. Further, the full UV absorption spectrum was recorded for each detected peak, confirming peak purity and identity. Using a microbore HPLC column and detection of UV absorbance at the maximal absorbance for each compound improve the sensitivity for all compounds. The detection limit of these compounds is 50 fmol (signal-to-noise ratio, S/N = 3). This method is useful in analyzing the temporal effect of a prolonged period of myocardial ischemia and reperfusion upon interstitial adenosine, inosine, hypoxanthine, xanthine, and uric acid concentrations in an in vivo canine model.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8660582     DOI: 10.1006/abio.1996.0246

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  7 in total

1.  Monitoring of metabolite gradients in tissue-engineered constructs.

Authors:  Olga A Boubriak; Jill P G Urban; Zhanfeng Cui
Journal:  J R Soc Interface       Date:  2006-10-22       Impact factor: 4.118

2.  A new data mining approach for profiling and categorizing kinetic patterns of metabolic biomarkers after myocardial injury.

Authors:  Christian Baumgartner; Gregory D Lewis; Michael Netzer; Bernhard Pfeifer; Robert E Gerszten
Journal:  Bioinformatics       Date:  2010-05-18       Impact factor: 6.937

3.  Quantitative analysis of adenosine using liquid chromatography/atmospheric pressure chemical ionization-tandem mass spectrometry (LC/APCI-MS/MS).

Authors:  Annelies Van Dycke; Alain Verstraete; Kristof Pil; Robrecht Raedt; Kristl Vonck; Detlev Boison; Paul Boon
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-04-03       Impact factor: 3.205

Review 4.  Inosine and hypoxanthine as novel biomarkers for cardiac ischemia: from bench to point-of-care.

Authors:  Don E Farthing; Christine A Farthing; Lei Xi
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-08

5.  Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury.

Authors:  Gregory D Lewis; Ru Wei; Emerson Liu; Elaine Yang; Xu Shi; Maryann Martinovic; Laurie Farrell; Aarti Asnani; Marcoli Cyrille; Arvind Ramanathan; Oded Shaham; Gabriel Berriz; Patricia A Lowry; Igor F Palacios; Murat Taşan; Frederick P Roth; Jiangyong Min; Christian Baumgartner; Hasmik Keshishian; Terri Addona; Vamsi K Mootha; Anthony Rosenzweig; Steven A Carr; Michael A Fifer; Marc S Sabatine; Robert E Gerszten
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

Review 6.  Application of metabolomics to cardiovascular biomarker and pathway discovery.

Authors:  Gregory D Lewis; Aarti Asnani; Robert E Gerszten
Journal:  J Am Coll Cardiol       Date:  2008-07-08       Impact factor: 24.094

7.  Uric acid is the major determinant of absorbance in spent dialysate allowing spectrophotometric evaluation of dialysis dose.

Authors:  Carlo Donadio; Dario Calia; Silvia Ghimenti; Massimo Onor; Elisa Colombini; Roger Fuoco; Fabio Di Francesco
Journal:  J Nephrol       Date:  2013-12-07       Impact factor: 3.902

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.